Literature DB >> 16703505

Genetic diversity of human metapneumovirus over 4 consecutive years in Australia.

Ian M Mackay1, Seweryn Bialasiewicz, Kevin C Jacob, Emily McQueen, Katherine E Arden, Michael D Nissen, Theo P Sloots.   

Abstract

The molecular epidemiologic profile of human metapneumovirus (hMPV) infection has likely been skewed toward certain genetic subtypes because of assay-design issues, and no comprehensive studies have been conducted to date. Here, reverse-transcription polymerase chain reaction was used to screen 10,319 specimens from patients presenting to hospitals with suspected respiratory tract infections during 2001-2004. After analysis of 727 Australian hMPV strains, 640 were assigned to 1 of 4 previously described subtypes. hMPV was the most common pathogen detected, and subtype B1 was the most common lineage. Concurrent, annual circulation of all 4 hMPV subtypes in our study population was common, with a single, usually different hMPV subtype predominating in each year.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703505     DOI: 10.1086/504260

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Detection and genetic diversity of human metapneumovirus in hospitalized children with acute respiratory infections in India.

Authors:  Sagarika Banerjee; Wayne M Sullender; Avinash Choudekar; Cherian John; Vikas Tyagi; Karen Fowler; Elliot J Lefkowitz; Shobha Broor
Journal:  J Med Virol       Date:  2011-10       Impact factor: 2.327

2.  Genomic analysis of four human metapneumovirus prototypes.

Authors:  Rohith Piyaratna; Sharon J Tollefson; John V Williams
Journal:  Virus Res       Date:  2011-06-28       Impact factor: 3.303

3.  Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.

Authors:  Sherry C Wen; Jennifer E Schuster; Pavlo Gilchuk; Kelli L Boyd; Sebastian Joyce; John V Williams
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

Review 4.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

5.  Real-time reverse transcriptase PCR assay for improved detection of human metapneumovirus.

Authors:  Jennifer Klemenc; S Asad Ali; Monika Johnson; Sharon J Tollefson; H Keipp Talbot; Tina V Hartert; Kathryn M Edwards; John V Williams
Journal:  J Clin Virol       Date:  2012-06-06       Impact factor: 3.168

6.  Population-based incidence of human metapneumovirus infection among hospitalized children.

Authors:  John V Williams; Kathryn M Edwards; Geoffrey A Weinberg; Marie R Griffin; Caroline B Hall; Yuwei Zhu; Peter G Szilagyi; Chiaoyin K Wang; Chin-Fen Yang; David Silva; Dan Ye; Richard R Spaete; James E Crowe
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 7.  Human metapneumovirus in adults.

Authors:  Lenneke E M Haas; Steven F T Thijsen; Leontine van Elden; Karen A Heemstra
Journal:  Viruses       Date:  2013-01-08       Impact factor: 5.048

8.  Genetic variability of attachment (G) and Fusion (F) protein genes of human metapneumovirus strains circulating during 2006-2009 in Kolkata, Eastern India.

Authors:  Anurodh S Agrawal; Tapasi Roy; Swati Ghosh; Mamta Chawla-Sarkar
Journal:  Virol J       Date:  2011-02-12       Impact factor: 4.099

9.  Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years.

Authors:  Chin-Fen Yang; Chiaoyin K Wang; Sharon J Tollefson; Rohith Piyaratna; Linda D Lintao; Marla Chu; Alexis Liem; Mary Mark; Richard R Spaete; James E Crowe; John V Williams
Journal:  Virol J       Date:  2009-09-09       Impact factor: 4.099

Review 10.  Breaking in: human metapneumovirus fusion and entry.

Authors:  Reagan G Cox; John V Williams
Journal:  Viruses       Date:  2013-01-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.